Larvol Delta - A2-Biotherapeuticsannounced-the-rst-patient-dosed-with-A2B543-initiating-the-second-arm-of-the-Phase-12-EVEREST2-study-NCT06051695

A2B543 - A2 Biotherap

https://www.businesswire.com/news/home/20260225216939/en/A2-Biotherapeutics-Doses-First-Patient-in-EVEREST-2-Study-with-A2B543-a-Logic-Gated-CAR-T-Cell-Therapy-Enhanced-with-a-Membrane-Tethered-IL-12-Booster

Feb 26, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next